We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Oral Contraceptive and D-Dimer Level—Reply

Anne Dompmartin, MD; Pascal Thibon, MD; Miikka Vikkula, MD, PhD; Laurence M. Boon, MD, PhD
Arch Dermatol. 2009;145(2):210-211. doi:10.1001/archdermatol.2008.568.
Text Size: A A A
Published online


In reply

Dr Kittisupamongkol noted that oral contraceptive medication is an important factor involved in the elevation of D-dimer levels. We agree, but this elevation is much lower than what we reported in our patients with venous malformations.1 In addition, the elevation that we observed was not associated with sex. Kluft et al,2 Johnson et al,3 and others (eg, Quehenberger et al4) have demonstrated slight elevation of D-dimer levels in patients taking contraceptive medication (mean level increases from 0.172 μg/mL to 0.351 μg/mL, which is still within the normal limits, <0.500 μg/mL). Among our patients, 42% had repeated D-dimer measurements higher than 0.500 μg/mL, and 61% of those D-dimer levels above 1.000 μg/mL. (To convert D-dimers to nanomoles per liter, multiply by 5.476.) Of our 140 patients with venous malformations, 43 were male, 43 were female younger than 17 years or older than 45 years, and 49 were women of reproductive age (Table). Wilcoxon and χ2 tests showed no statistical correlation between a woman being of reproductive age and elevated D-dimer levels (P = .69 and P = .38, respectively).

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





February 1, 2009
Weekitt Kittisupamongkol, MD
Arch Dermatol. 2009;145(2):210. doi:10.1001/archdermatol.2008.565.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles